SCHEMBL28873447

SCHEMBL28873447

COc1ccc(C2=NN(c3cccc(F)c3)C(=O)C(C(=O)O)C2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.51
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
PDE5A O76074 1/20 0.46
NR3C2 P08235 1/20 0.46
PTGS2 P35354 2/20 0.46
PDE4A P27815 1/20 0.45
PDE4B Q07343 1/20 0.45
PDE4C Q08493 1/20 0.45
PDE4D Q08499 1/20 0.45
MAOA P21397 2/20 0.44
MAOB P27338 2/20 0.44
CACNA1H O95180 1/20 0.43
EGFR P00533 1/20 0.43
ERBB2 P04626 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
ALDH1A1 P00352 1/20 0.42
ADRB2 P07550 1/20 0.42
HPGD P15428 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19642610 0.91 KDM4E (0.48) KDM4ENPC1RAB9APDE5ANR3C2
SCHEMBL30187464 0.91 KDM4E (0.48) KDM4ENPC1RAB9APDE5ANR3C2
SCHEMBL28299533 0.88 KDM4E (0.41) KDM4EPDE5ANR3C2PTGS2PDE4A
SCHEMBL28297923 0.88 MEN1 (0.41) KDM4ENR3C2PDE4APDE4BPDE4C
SCHEMBL28299380 0.85 MEN1 (0.49) KDM4ENPC1RAB9ANR3C2PDE4A
SCHEMBL28297925 0.84 CACNA1H (0.39) KDM4ENR3C2PTGS2PDE4APDE4B
SCHEMBL30187456 0.81 MEN1 (0.41) KDM4EPDE4APDE4BPDE4CPDE4D
SCHEMBL30187450 0.81 KDM4E (0.41) KDM4EPDE5APTGS2PDE4APDE4B
SCHEMBL19643410 0.81 MEN1 (0.41) KDM4EPDE4APDE4BPDE4CPDE4D
SCHEMBL19642572 0.81 KDM4E (0.41) KDM4EPDE5APTGS2PDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109863140-A 3- oxo -2,6- diphenyl -2,3- dihydrogen dazin -4- formamide 拜耳医药股份有限公司 2019-06-07 CN disclosed